Cargando…
Depression: A Modifiable Risk Factor for Poor Outcomes in Fibromyalgia
BACKGROUND: About 4 out of 10 fibromyalgia patients suffer from depression. The European Alliance of Associations for Rheumatology (EULAR) guidelines recommend using antidepressants to treat fibromyalgia. OBJECTIVE: To determine predictors of improved outcomes following a multicomponent treatment pr...
Autores principales: | Munipalli, Bala, Allman, Madeleine E., Chauhan, Mohit, Niazi, Shehzad K., Rivera, Fernando, Abril, Andy, Wang, Benjamin, Wieczorek, Mikolaj A., Hodge, David O., Knight, Dacre, Perlman, Adam, Abu Dabrh, Abd Moain, Dudenkov, Daniel, Bruce, Barbara K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424873/ https://www.ncbi.nlm.nih.gov/pubmed/36036260 http://dx.doi.org/10.1177/21501319221120738 |
Ejemplares similares
-
Prevalence, Demographics, and Risk of Severe Acute COVID-19
por: Munipalli, Bala, et al.
Publicado: (2021) -
Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management
por: Munipalli, Bala, et al.
Publicado: (2022) -
Association of Vitamin B12, Vitamin D, and Thyroid-Stimulating Hormone With Fatigue and Neurologic Symptoms in Patients With Fibromyalgia
por: Munipalli, Bala, et al.
Publicado: (2022) -
Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19
por: Knight, Dacre R.T., et al.
Publicado: (2022) -
Physician Satisfaction With Telemedicine During the COVID-19 Pandemic: The Mayo Clinic Florida Experience
por: Malouff, Timothy D., et al.
Publicado: (2021)